1149 related articles for article (PubMed ID: 33767397)
1. Engineering luminescent biosensors for point-of-care SARS-CoV-2 antibody detection.
Elledge SK; Zhou XX; Byrnes JR; Martinko AJ; Lui I; Pance K; Lim SA; Glasgow JE; Glasgow AA; Turcios K; Iyer NS; Torres L; Peluso MJ; Henrich TJ; Wang TT; Tato CM; Leung KK; Greenhouse B; Wells JA
Nat Biotechnol; 2021 Aug; 39(8):928-935. PubMed ID: 33767397
[TBL] [Abstract][Full Text] [Related]
2. Engineering luminescent biosensors for point-of-care SARS-CoV-2 antibody detection.
Elledge SK; Zhou XX; Byrnes JR; Martinko AJ; Lui I; Pance K; Lim SA; Glasgow JE; Glasgow AA; Turcios K; Iyer N; Torres L; Peluso MJ; Henrich TJ; Wang TT; Tato CM; Leung KK; Greenhouse B; Wells JA
medRxiv; 2020 Aug; ():. PubMed ID: 32839788
[TBL] [Abstract][Full Text] [Related]
3. Serological assays and host antibody detection in coronavirus-related disease diagnosis.
Dowlatshahi S; Shabani E; Abdekhodaie MJ
Arch Virol; 2021 Mar; 166(3):715-731. PubMed ID: 33492524
[TBL] [Abstract][Full Text] [Related]
4. A rapid, point-of-care red blood cell agglutination assay detecting antibodies against SARS-CoV-2.
Kruse RL; Huang Y; Smetana H; Gehrie EA; Amukele TK; Tobian AAR; Mostafa HH; Wang ZZ
Biochem Biophys Res Commun; 2021 May; 553():165-171. PubMed ID: 33773139
[TBL] [Abstract][Full Text] [Related]
5. SARS-CoV-2 Antibody Rapid Tests: Valuable Epidemiological Tools in Challenging Settings.
Saluzzo F; Mantegani P; Poletti De Chaurand V; Quaresima V; Cugnata F; Di Serio C; Macé A; De Vos M; Sacks JA; Cirillo DM
Microbiol Spectr; 2021 Oct; 9(2):e0025021. PubMed ID: 34549999
[TBL] [Abstract][Full Text] [Related]
6. Detection of SARS-CoV-2-specific antibodies via rapid diagnostic immunoassays in COVID-19 patients.
Chansaenroj J; Yorsaeng R; Posuwan N; Puenpa J; Sudhinaraset N; Chirathaworn C; Poovorawan Y
Virol J; 2021 Mar; 18(1):52. PubMed ID: 33750394
[TBL] [Abstract][Full Text] [Related]
7. Remote Fingerstick Blood Collection for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Antibody Testing.
Garcia-Beltran WF; Miller TE; Kirkpatrick G; Nixon A; Astudillo MG; Yang D; Mahanta LM; Murali M; Dighe AS; Lennerz J; Thierauf J; Naranbhai V; Iafrate AJ
Arch Pathol Lab Med; 2021 Apr; 145(4):415-418. PubMed ID: 33264390
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of a Surrogate Enzyme-Linked Immunosorbent Assay-Based Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) cPass Neutralization Antibody Detection Assay and Correlation With Immunoglobulin G Commercial Serology Assays.
Nandakumar V; Profaizer T; Lozier BK; Elgort MG; Larragoite ET; Williams ESCP; Solis-Leal A; Lopez JB; Berges BK; Planelles V; Rychert J; Slev PR; Delgado JC
Arch Pathol Lab Med; 2021 Oct; 145(10):1212-1220. PubMed ID: 34181714
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of Three Quantitative Anti-SARS-CoV-2 Antibody Immunoassays.
Chapuy-Regaud S; Miédougé M; Abravanel F; Da Silva I; Porcheron M; Fillaux J; Diméglio C; Izopet J
Microbiol Spectr; 2021 Dec; 9(3):e0137621. PubMed ID: 34937195
[TBL] [Abstract][Full Text] [Related]
10. Using Split Luminescent Biosensors for SARS-CoV-2 Antibody Detection in Serum, Plasma, and Blood Samples.
Elledge SK; Eigl I; Phelps M; McClinton K; Zhou XX; Leung KK; Tato CM; Wells JA
Curr Protoc; 2022 Oct; 2(10):e521. PubMed ID: 36200787
[TBL] [Abstract][Full Text] [Related]
11. A comparative review of immunoassays for COVID-19 detection.
Mohit E; Rostami Z; Vahidi H
Expert Rev Clin Immunol; 2021 Jun; 17(6):573-599. PubMed ID: 33787412
[No Abstract] [Full Text] [Related]
12. A Multiplex Noninvasive Salivary Antibody Assay for SARS-CoV-2 Infection and Its Application in a Population-Based Survey by Mail.
Egorov AI; Griffin SM; Fuzawa M; Kobylanski J; Grindstaff R; Padgett W; Simmons S; Hallinger DR; Styles JN; Wickersham L; Sams E; Hudgens E; Wade TJ
Microbiol Spectr; 2021 Oct; 9(2):e0069321. PubMed ID: 34523986
[TBL] [Abstract][Full Text] [Related]
13. An Assessment of Serological Assays for SARS-CoV-2 as Surrogates for Authentic Virus Neutralization.
Wohlgemuth N; Whitt K; Cherry S; Kirkpatrick Roubidoux E; Lin CY; Allison KJ; Gowen A; Freiden P; Allen EK; ; Gaur AH; Estepp JH; Tang L; Mori T; Hijano DR; Hakim H; McGargill MA; Krammer F; Whitt MA; Wolf J; Thomas PG; Schultz-Cherry S
Microbiol Spectr; 2021 Oct; 9(2):e0105921. PubMed ID: 34704832
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of Commercial Rapid Lateral Flow Tests, Alone or in Combination, for SARS-CoV-2 Antibody Testing.
Fischer PU; Fischer K; Curtis KC; Huang Y; Fetcho N; Goss CW; Weil GJ
Am J Trop Med Hyg; 2021 Jun; 105(2):378-386. PubMed ID: 34181574
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of diagnostic accuracy of 10 serological assays for detection of SARS-CoV-2 antibodies.
Gutiérrez-Cobos A; Gómez de Frutos S; Domingo García D; Navarro Lara E; Yarci Carrión A; Fontán García-Rodrigo L; Fraile Torres AM; Cardeñoso Domingo L
Eur J Clin Microbiol Infect Dis; 2021 May; 40(5):955-961. PubMed ID: 33236268
[TBL] [Abstract][Full Text] [Related]
16. Detection of SARS-CoV-2 Antibodies in Oral Fluid Obtained Using a Rapid Collection Device.
MacMullan MA; Chellamuthu P; Mades A; Das S; Turner F; Slepnev VI; Ibrayeva A
J Clin Microbiol; 2021 Jan; 59(2):. PubMed ID: 33234589
[TBL] [Abstract][Full Text] [Related]
17. Inference of SARS-CoV-2 spike-binding neutralizing antibody titers in sera from hospitalized COVID-19 patients by using commercial enzyme and chemiluminescent immunoassays.
Valdivia A; Torres I; Latorre V; Francés-Gómez C; Albert E; Gozalbo-Rovira R; Alcaraz MJ; Buesa J; Rodríguez-Díaz J; Geller R; Navarro D
Eur J Clin Microbiol Infect Dis; 2021 Mar; 40(3):485-494. PubMed ID: 33404891
[TBL] [Abstract][Full Text] [Related]
18. Dual lateral flow optical/chemiluminescence immunosensors for the rapid detection of salivary and serum IgA in patients with COVID-19 disease.
Roda A; Cavalera S; Di Nardo F; Calabria D; Rosati S; Simoni P; Colitti B; Baggiani C; Roda M; Anfossi L
Biosens Bioelectron; 2021 Jan; 172():112765. PubMed ID: 33126179
[TBL] [Abstract][Full Text] [Related]
19. Testing-on-a-probe biosensors reveal association of early SARS-CoV-2 total antibodies and surrogate neutralizing antibodies with mortality in COVID-19 patients.
Yang HS; Racine-Brzostek SE; Karbaschi M; Yee J; Dillard A; Steel PAD; Lee WT; McDonough KA; Qiu Y; Ketas TJ; Francomano E; Klasse PJ; Hatem L; Westblade L; Wu H; Chen H; Zuk R; Tan H; Girardin RC; Dupuis AP; Payne AF; Moore JP; Cushing MM; Chadburn A; Zhao Z
Biosens Bioelectron; 2021 Apr; 178():113008. PubMed ID: 33515984
[TBL] [Abstract][Full Text] [Related]
20. Performance evaluation of antibody-based point-of-care devices intended for the identification of immune responses to SARS-CoV-2.
Furuya AKM; Wagner C; Connors J; Bodnar J; Miller T; Ryman NL; Warszycki CJ; Wong SJ; Walsh AC; McDonough KA; Lee WT
Diagn Microbiol Infect Dis; 2021 Apr; 99(4):115298. PubMed ID: 33418405
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
